Skip to main content

Table 2 Planned analyses

From: SARS-CoV-2-specific immune responses in elderly and immunosuppressed participants and patients with hematologic disease or checkpoint inhibition in solid tumors: study protocol of the prospective, observational CoCo immune study

Type of specimen

Planned analyses

Serum/plasma

•ELISA for SARS-COV-2 S1 specific IgG/IgA

•Multiplex analyses of SARS-COV-2 S1, S2, RBD

•ELISA for Influenza A/B specific IgG

PBMC

•SARS-CoV-2 Interferon Gamma Release Assay (IGRA) in HO subgroups

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us